A citation-based method for searching scientific literature

W E Wright, M A Piatyszek, W E Rainey, W Byrd, J W Shay. Dev Genet 1996
Times Cited: 947







List of co-cited articles
1320 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis.
Zheng-Sheng Wu, Qiang Wu, Chao-Qun Wang, Xiao-Nan Wang, Yan Wang, Jing-Jing Zhao, Shan-Shan Mao, Gui-Hong Zhang, Nong Zhang, Xiao-Chun Xu. BMC Cancer 2010
81
1



DNA damage and repair in human oocytes and embryos: a review.
Yves Ménézo, Brian Dale, Marc Cohen. Zygote 2010
134
1

Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation.
Domenico Migliorini, Davide Danovi, Emanuela Colombo, Roberta Carbone, Pier Giuseppe Pelicci, Jean-Christophe Marine. J Biol Chem 2002
63
1

Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study.
Omid Fotouhi, Maral Adel Fahmideh, Magnus Kjellman, Luqman Sulaiman, Anders Höög, Jan Zedenius, Jamileh Hashemi, Catharina Larsson. Epigenetics 2014
30
3

An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes.
G N Filippova, S Fagerlie, E M Klenova, C Myers, Y Dehner, G Goodwin, P E Neiman, S J Collins, V V Lobanenkov. Mol Cell Biol 1996
397
1


Mdm proteins: critical regulators of embry ogenesis and homeostasis.
Sydney M Moyer, Connie A Larsson, Guillermina Lozano. J Mol Cell Biol 2017
18
5

Widespread overexpression of epitope-tagged Mdm4 does not accelerate tumor formation in vivo.
Sarah De Clercq, Agnieszka Gembarska, Geertrui Denecker, Marion Maetens, Michael Naessens, Katharina Haigh, Jody J Haigh, Jean-Christophe Marine. Mol Cell Biol 2010
30
3


Characterization of the human p53 gene.
P Lamb, L Crawford. Mol Cell Biol 1986
352
1

Expression of arf tumor suppressor in spermatogonia facilitates meiotic progression in male germ cells.
Michelle L Churchman, Ignasi Roig, Maria Jasin, Scott Keeney, Charles J Sherr. PLoS Genet 2011
24
4

TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
Zhicheng Zhou, Zhongzhong Ji, You Wang, Jian Li, Hui Cao, Helen He Zhu, Wei-Qiang Gao. Gastroenterology 2014
94
1

Alternative and aberrant splicing of MDM2 mRNA in human cancer.
Frank Bartel, Helge Taubert, Linda C Harris. Cancer Cell 2002
160
1


Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells.
Avedis Kazanjian, Deeann Wallis, Nicholas Au, Rupesh Nigam, Koen J T Venken, Philip T Cagle, Burton F Dickey, Hugo J Bellen, C Blake Gilks, H Leighton Grimes. Cancer Res 2004
62
1

Gain-of-function mutation in ADULT syndrome reveals the presence of a second transactivation domain in p63.
Pascal H G Duijf, Kaate R J Vanmolkot, Peter Propping, Waltraut Friedl, Elmar Krieger, Frank McKeon, Volker Dötsch, Han G Brunner, Hans van Bokhoven. Hum Mol Genet 2002
94
1

p73: From the p53 shadow to a major pharmacological target in anticancer therapy.
Helena Ramos, Liliana Raimundo, Lucília Saraiva. Pharmacol Res 2020
4
25

Predicting the biologic behavior of ductal carcinoma in situ: an analysis of molecular markers.
T J Hieken, M Farolan, S D'Alessandro, J M Velasco. Surgery 2001
26
3


MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer.
Veronica Tisato, Rebecca Voltan, Arianna Gonelli, Paola Secchiero, Giorgio Zauli. J Hematol Oncol 2017
118
1

Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains.
Pamela Ghioni, Fabrizio Bolognese, Pascal H G Duijf, Hans Van Bokhoven, Roberto Mantovani, Luisa Guerrini. Mol Cell Biol 2002
184
1


Transcription factors Sp1 and p73 control the expression of the proapoptotic protein NOXA in the response of testicular embryonal carcinoma cells to cisplatin.
Lara Grande, Gabriel Bretones, Manuel Rosa-Garrido, Eva M Garrido-Martin, Teresa Hernandez, Susana Fraile, Luisa Botella, Enrique de Alava, August Vidal, Xavier Garcia del Muro,[...]. J Biol Chem 2012
37
2

Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression.
Michael S Cunnington, Mauro Santibanez Koref, Bongani M Mayosi, John Burn, Bernard Keavney. PLoS Genet 2010
273
1

Identification of novel ARF binding proteins by two-hybrid screening.
Van Tompkins, Jussara Hagen, Valerie P Zediak, Dawn E Quelle. Cell Cycle 2006
33
3

Noxa: Role in Cancer Pathogenesis and Treatment.
Rami Z Morsi, Rouba Hage-Sleiman, Hadile Kobeissy, Ghassan Dbaibo. Curr Cancer Drug Targets 2018
14
7

Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status.
M Esteller, S Tortola, M Toyota, G Capella, M A Peinado, S B Baylin, J G Herman. Cancer Res 2000
420
1

MDM2 promotes epithelial-mesenchymal transition and metastasis of ovarian cancer SKOV3 cells.
Ying Chen, Dan-Dan Wang, Ye-Ping Wu, Dan Su, Tian-Yi Zhou, Ren-Hua Gai, Ying-Ying Fu, Lin Zheng, Qiao-Jun He, Hong Zhu,[...]. Br J Cancer 2017
38
2

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours.
A Yang, N Walker, R Bronson, M Kaghad, M Oosterwegel, J Bonnin, C Vagner, H Bonnet, P Dikkes, A Sharpe,[...]. Nature 2000
824
1

The Janus face of p21.
Konstantinos Evangelou, Panagiotis Galanos, Vassilis G Gorgoulis. Mol Cell Oncol 2016
4
25

p63 the guardian of human reproduction.
Ivano Amelio, Francesca Grespi, Margherita Annicchiarico-Petruzzelli, Gerry Melino. Cell Cycle 2012
41
2

Depletion of CTCF in Breast Cancer Cells Selectively Induces Cancer Cell Death via p53.
Ji-Yeon Lee, Muhammad Mustafa, Clara Yuri Kim, Myoung Hee Kim. J Cancer 2017
10
10

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer.
G Hofstetter, A Berger, E Schuster, A Wolf, G Hager, I Vergote, I Cadron, J Sehouli, E I Braicu, S Mahner,[...]. Br J Cancer 2011
31
3

p53 Family and Cellular Stress Responses in Cancer.
Johanna Pflaum, Sophie Schlosser, Martina Müller. Front Oncol 2014
152
1

Transient expression of the Arf tumor suppressor during male germ cell and eye development in Arf-Cre reporter mice.
Adam Gromley, Michelle L Churchman, Frederique Zindy, Charles J Sherr. Proc Natl Acad Sci U S A 2009
33
3

Identification of novel genes coding for small expressed RNAs.
M Lagos-Quintana, R Rauhut, W Lendeckel, T Tuschl. Science 2001
1

p63 is a p53 homologue required for limb and epidermal morphogenesis.
A A Mills, B Zheng, X J Wang, H Vogel, D R Roop, A Bradley. Nature 1999
1

Loss of wild-type p53 promotes mutant p53-driven metastasis through acquisition of survival and tumor-initiating properties.
Mizuho Nakayama, Chang Pyo Hong, Hiroko Oshima, Eri Sakai, Seong-Jin Kim, Masanobu Oshima. Nat Commun 2020
10
10

Modulation of p53 function by SET8-mediated methylation at lysine 382.
Xiaobing Shi, Ioulia Kachirskaia, Hiroshi Yamaguchi, Lisandra E West, Hong Wen, Evelyn W Wang, Sucharita Dutta, Ettore Appella, Or Gozani. Mol Cell 2007
296
1

Mdm2 promotes the rapid degradation of p53.
Y Haupt, R Maya, A Kazaz, M Oren. Nature 1997
1

Aberrant expression of HDMX proteins in tumor cells correlates with wild-type p53.
Y F Ramos, R Stad, J Attema, L T Peltenburg, A J van der Eb, A G Jochemsen. Cancer Res 2001
123
1

Is p21 an oncogene?
Andrei L Gartel. Mol Cancer Ther 2006
54
1

Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis.
S N Jones, A R Hancock, H Vogel, L A Donehower, A Bradley. Proc Natl Acad Sci U S A 1998
309
1

p63 and p73 are required for p53-dependent apoptosis in response to DNA damage.
Elsa R Flores, Kenneth Y Tsai, Denise Crowley, Shomit Sengupta, Annie Yang, Frank McKeon, Tyler Jacks. Nature 2002
670
1

Cytogenetics of primary testicular nonseminoma, residual mature teratoma, and growing teratoma lesion in individual patients.
J van Echten, D T Sleijfer, J Wiersema, H Schraffordt Koops, J W Oosterhuis, B de Jong. Cancer Genet Cytogenet 1997
23
4

Amplification of a gene encoding a p53-associated protein in human sarcomas.
J D Oliner, K W Kinzler, P S Meltzer, D L George, B Vogelstein. Nature 1992
1

TRIM23 overexpression is a poor prognostic factor and contributes to carcinogenesis in colorectal cancer.
Yudong Han, Ye Tan, Yuanyuan Zhao, Yongchun Zhang, Xinjia He, Li Yu, Haiping Jiang, Haijun Lu, Haiying Tian. J Cell Mol Med 2020
10
10

Why are there hotspot mutations in the TP53 gene in human cancers?
Evan H Baugh, Hua Ke, Arnold J Levine, Richard A Bonneau, Chang S Chan. Cell Death Differ 2018
117
1


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.